ASKA Pharmaceutical Holdings

4886.TTSE PRIMEPharmaceutical
In English · 15
Mon, May 25 · JST1 filing
15:32MATERIALASKA Pharmaceutical Holdings · Share transfer
Wed, Apr 8 · JST1 filing
15:335% STAKEASKA Pharmaceutical Holdings · Dalton Investments, Inc. + 2 joint holders · 20.49% → 21.32%+0.83pp
Tue, May 13 · JST1 filing
16:335% STAKEASKA Pharmaceutical Holdings · Dalton Investments, Inc. + 2 joint holders · 19.43% → 20.49%+1.06pp
Fri, Mar 28 · JST1 filing
15:315% STAKEASKA Pharmaceutical Holdings · Dalton Investments, Inc. + 2 joint holders · 17.94% → 19.43%+1.49pp
Wed, Mar 5 · JST1 filing
15:325% STAKEASKA Pharmaceutical Holdings · Dalton Investments, Inc. + 2 joint holders · 16.92% → 17.94%+1.02pp
Fri, Feb 7 · JST1 filing
15:41MATERIALASKA Pharmaceutical Holdings · Change in parent company or specified subsidiary
Thu, Jan 30 · JST1 filing
15:315% STAKEASKA Pharmaceutical Holdings · NIPPON ACTIVE VALUE FUND PLC + 2 joint holders · 15.89% → 16.92%+1.03pp
Fri, Jan 10 · JST1 filing
15:315% STAKEASKA Pharmaceutical Holdings · NIPPON ACTIVE VALUE FUND PLC + 2 joint holders · 14.90% → 15.89%+0.99pp
Thu, Dec 5 · JST1 filing
15:325% STAKEASKA Pharmaceutical Holdings · NIPPON ACTIVE VALUE FUND PLC + 2 joint holders · 13.88% → 14.90%+1.02pp
Mon, Dec 2 · JST1 filing
15:335% STAKEASKA Pharmaceutical Holdings · Dalton Investments, Inc. + 2 joint holders · 12.82% → 13.88%+1.06pp
Thu, Nov 7 · JST1 filing
15:405% STAKEASKA Pharmaceutical Holdings · NIPPON ACTIVE VALUE FUND PLC + 2 joint holders · 11.82% → 12.82%+1.00pp
Wed, Oct 16 · JST1 filing
15:075% STAKEASKA Pharmaceutical Holdings · NIPPON ACTIVE VALUE FUND PLC + 2 joint holders · 10.80% → 11.82%+1.02pp
Wed, Sep 18 · JST1 filing
15:035% STAKEASKA Pharmaceutical Holdings · NIPPON ACTIVE VALUE FUND PLC + 2 joint holders · 9.77% → 10.80%+1.03pp
Tue, Aug 13 · JST1 filing
15:045% STAKEASKA Pharmaceutical Holdings · NIPPON ACTIVE VALUE FUND PLC + 2 joint holders · 8.71% → 9.77%+1.06pp
Fri, Jul 19 · JST1 filing
15:035% STAKEASKA Pharmaceutical Holdings · NIPPON ACTIVE VALUE FUND PLC + 2 joint holders · 7.69% → 8.71%+1.02pp
All EDINET filings · 59
FiledDocumentFilerSource
2024-06-25CEO/CFO certificationASKA Pharmaceutical Holdings CO., Ltd.S100TOU7
2024-06-25Internal control reportASKA Pharmaceutical Holdings CO., Ltd.S100TOU1
2024-06-25Annual reportASKA Pharmaceutical Holdings CO., Ltd.S100TOTO
2024-04-15Large shareholding reportNIPPON ACTIVE VALUE FUND PLCS100T923
2024-04-04Large shareholding reportNIPPON ACTIVE VALUE FUND PLCS100T7K4
2024-02-09CEO/CFO certificationASKA Pharmaceutical Holdings CO., Ltd.S100SSGM
2024-02-09Quarterly reportASKA Pharmaceutical Holdings CO., Ltd.S100SSGE
2024-01-11Large shareholding reportRelated to S100SCKPNIPPON ACTIVE VALUE FUND PLCS100SKYQ
2023-11-24Large shareholding reportNIPPON ACTIVE VALUE FUND PLCS100SCKP
2023-11-10CEO/CFO certificationASKA Pharmaceutical Holdings CO., Ltd.S100S72B
2023-11-10Quarterly reportASKA Pharmaceutical Holdings CO., Ltd.S100S71T
2023-08-07Quarterly reportASKA Pharmaceutical Holdings CO., Ltd.S100RJLW
2023-06-27CEO/CFO certificationASKA Pharmaceutical Holdings CO., Ltd.S100R65N
2023-06-27Internal control reportASKA Pharmaceutical Holdings CO., Ltd.S100R65C
2023-06-27Annual reportASKA Pharmaceutical Holdings CO., Ltd.S100R645
2023-02-09Quarterly reportASKA Pharmaceutical Holdings CO., Ltd.S100Q4CE
2022-12-19Large shareholding reportMitsubishi UFJ Financial Group, Inc.S100PSTH
2022-11-10Quarterly reportASKA Pharmaceutical Holdings CO., Ltd.S100PIUD
2022-08-08Quarterly reportASKA Pharmaceutical Holdings CO., Ltd.S100OVV1
2022-06-28CEO/CFO certificationASKA Pharmaceutical Holdings CO., Ltd.S100OHXG
2022-06-28Internal control reportASKA Pharmaceutical Holdings CO., Ltd.S100OHXD
2022-06-28Annual reportASKA Pharmaceutical Holdings CO., Ltd.S100OHVN
2022-06-09Large shareholding reportRelated to S100MDSYZERIA PHARMCEUTICAL CO., LTD.S100O7UL
2022-05-23Amended quarterly reportAmends S100ND9GASKA Pharmaceutical Holdings CO., Ltd.S100O3GV
2022-05-23Amended quarterly reportAmends S100MQVGASKA Pharmaceutical Holdings CO., Ltd.S100O3GS
2022-05-23Amended quarterly reportAmends S100M7F0ASKA Pharmaceutical Holdings CO., Ltd.S100O3GO
2022-02-07Quarterly reportASKA Pharmaceutical Holdings CO., Ltd.S100ND9G
2021-11-08Quarterly reportASKA Pharmaceutical Holdings CO., Ltd.S100MQVG
2021-08-10Quarterly reportASKA Pharmaceutical Holdings CO., Ltd.S100M7F0

EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 6 financial reports not structured yet.

Not structured yet
—quarterlyoriginal indexedS100O3GV
—quarterlyoriginal indexedS100O3GS
—quarterlyoriginal indexedS100O3GO
2021-12-31quarterlyoriginal indexedS100ND9G
2021-09-30quarterlyoriginal indexedS100MQVG
2021-06-30quarterlyoriginal indexedS100M7F0